Search results
Added:
1 year ago
HFA 24 - We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, US) to discuss the findings from a study of four large-scale placebo controlled-trials investigating the timing of cardio-kidney protection with SGLT2 inhibitors.4 trials that sampled distinct patient populations were enrolled in the trial - the CANVAS program, the CREDENCE trial, DAPA-HF and DELIVER. Across each…
View more
Added:
1 year ago
ACC 2024 — Dr Ami B Bhatt, Chief Innovation Officer of ACC, joins us to highlight key information regarding artificial intelligence innovations in cardiology in 2024.Dr Bhatt discusses the potential progress and innovation that artificial intelligence can provide in clinical medicine, including risk predictions, artificial intelligence use in EKGs, large language models and virtual learning…
View more
Added:
1 year ago
AHA 23 — Dr Michael Honigberg (Massachusetts General Hospital, US) highlights key 2023 cardiology updates, featuring novel data from AHA Scientific Sessions.Dr Honigberg provides commentary on the new SELECT trial outcomes and emphasises the incretin mimetic, semaglutide's role in cardiovascular medicine. He delves into lipid management with a focus on the CLEAR trial data and the incorporation…
View more
An Expert Approach to Cardio-Renal Protection in CKD
Video Series
An Expert Approach to Cardio-Renal Protection in CKD
Video Series
Start date:
Jul 13, 2023
This engaging session features the collaborative efforts of interventional and heart failure cardiologists in revolutionizing the management of ST-Elevation Myocardial Infarction (STEMI) and its impact on heart failure.
Through a dynamic fireside chat format, our esteemed panelists will explore groundbreaking approaches and advancements that are reshaping STEMI care. They will delve into…
View more
Start date:
Apr 18, 2024
Start date:
Mar 11, 2024
e-SPACE CRM 2024 - Day 2
Start date:
Mar 23, 2024
Broadcast
e-SPACE CRM 2024 - Day 1
Start date:
Mar 22, 2024
Broadcast
